Combining CPS1 inhibition and PD-1 blockade effectively suppressed lung cancer metastasis and significantly prolonged the survival of mice, by directly targeting tumor cells via the metabolic pathway while concurrently reinvigorating the anti-tumor activity of CD8+ T cells. Here, CPS1 is linked to lung carcinoma.